Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cotinine: effects with and without nicotine

D Hatsukami1, P R Pentel, J Jensen

  • 1University of Minnesota, Department of Psychiatry, Minneapolis 55455, USA.

Psychopharmacology
|March 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel approach to cervical dilation for second-trimester dilation and evacuation in a myomatous uterus.

Contraception·2025
Same author

Evaluating the prospective utility of pharmacogenetics reporting among Canadian Armed Forces personnel receiving pharmacotherapy: a preliminary assessment towards precision psychiatric care.

BMJ military health·2023
Same author

A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer.

ESMO open·2023
Same author

Developing a platform for Fresnel diffractive radiography with 1 μm spatial resolution at the National Ignition Facility.

The Review of scientific instruments·2023
Same author

UPPER ARM CONTOURING - A NARRATIVE REVIEW.

Georgian medical news·2023
Same author

PIGMENTED NODULAR CYSTIC HIDRADENOMA OF THE ANKLE.

Georgian medical news·2021
Same journal

Sotagliflozin pretreatment attenuates acute LPS-induced depression-like behavioral abnormalities and modulates the gut microbiota-immune-brain axis.

Psychopharmacology·2026
Same journal

GlyT1 inhibition enhances working memory in the mouse TUNL task and normalizes NMDA antagonist-induced network activity.

Psychopharmacology·2026
Same journal

Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice.

Psychopharmacology·2026
Same journal

Cannabidiol in the anterior insular cortex attenuates chronic neuropathic pain and comorbid anxiety- and depression-like behaviors: involvement of CB<sub>1</sub> and 5-HT<sub>1A</sub> receptor signaling.

Psychopharmacology·2026
Same journal

Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea.

Psychopharmacology·2026
Same journal

Suicide attempt risk among patients receiving methylphenidate: a retrospective cohort study.

Psychopharmacology·2026
See all related articles

High concentrations of cotinine, a nicotine metabolite, may block nicotine

Area of Science:

  • Pharmacology and Toxicology
  • Addiction Research

Background:

  • Nicotine replacement therapy (NRT) is a common method for smoking cessation.
  • Cotinic is a major metabolite of nicotine, and its role during smoking abstinence is not fully understood.
  • Understanding cotinine's effects is crucial for optimizing smoking cessation strategies.

Purpose of the Study:

  • To investigate the effects of cotinine, nicotine patch, and their combination on physiological, subjective, and performance measures during cigarette abstinence.
  • To compare the efficacy of cotinine and nicotine patch in alleviating withdrawal symptoms.

Main Methods:

  • A 2x2 factorial design study involving 106 subjects.
  • Four treatment conditions: nicotine patch vs. placebo patch, and oral cotinine vs. placebo drug.

Related Experiment Videos

  • Subjects were required to be abstinent from cigarettes for 14 days while receiving study medication.

    • Main Results:

    • Cotinine administration led to serum concentrations 3-4 times higher than during ad lib smoking.
    • Nicotine patch alone reduced self-reported withdrawal symptoms.
    • Cotinine alone had no effect on withdrawal symptoms; when combined with the nicotine patch, it negated the patch's beneficial effects.

    Conclusions:

    • Cotinine appears to antagonize nicotine's ability to alleviate withdrawal symptoms at high concentrations.
    • These findings suggest cotinine may interfere with nicotine replacement therapy efficacy.
    • Further research is needed to elucidate the mechanisms underlying cotinine's antagonistic effects.